ATM and familial pancreatic carcinoma: In one of the largest studies to date of 3030 pancreatic cancer patients, pathogenic germline ATM variants were identified in 69 patients (2.3%; 95% confidence interval (CI), 4.38–7.33) [25], including 11 patients with FPC.